A. Prasanth Saraswati

773 total citations
13 papers, 531 citations indexed

About

A. Prasanth Saraswati is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, A. Prasanth Saraswati has authored 13 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in A. Prasanth Saraswati's work include Peptidase Inhibition and Analysis (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Click Chemistry and Applications (2 papers). A. Prasanth Saraswati is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Click Chemistry and Applications (2 papers). A. Prasanth Saraswati collaborates with scholars based in Italy, India and United States. A. Prasanth Saraswati's co-authors include Namballa Hari Krishna, Giuseppe Campiani, Sandra Gemma, Margherita Brindisi, Stefania Butini, Simone Brogi, Ähmed Kamal, S.M. Ali Hussaini, Bathini Nagendra Babu and Mallika Alvala and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Drug Discovery Today.

In The Last Decade

A. Prasanth Saraswati

13 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Prasanth Saraswati Italy 10 295 163 85 72 64 13 531
Andrew J. Ambrose United States 13 320 1.1× 87 0.5× 27 0.3× 14 0.2× 19 0.3× 31 485
J. Jacob Strouse United States 11 215 0.7× 67 0.4× 85 1.0× 26 0.4× 12 0.2× 15 505
Xingguang Cai China 14 296 1.0× 60 0.4× 18 0.2× 152 2.1× 19 0.3× 21 456
Christopher Aquino United States 11 389 1.3× 99 0.6× 37 0.4× 26 0.4× 21 0.3× 13 695
Shayli Varasteh Moradi Australia 9 282 1.0× 100 0.6× 36 0.4× 44 0.6× 18 0.3× 16 445
Dominic A. Colosimo United States 7 263 0.9× 67 0.4× 64 0.8× 17 0.2× 40 0.6× 8 452
Marcella Nunes Melo‐Braga Brazil 12 445 1.5× 36 0.2× 65 0.8× 68 0.9× 16 0.3× 27 635
Zhenyu Li China 12 154 0.5× 66 0.4× 61 0.7× 10 0.1× 126 2.0× 28 512
Jennifer M. Pearson Canada 13 291 1.0× 85 0.5× 81 1.0× 10 0.1× 22 0.3× 24 551
Douglas Wisniewski United States 10 308 1.0× 43 0.3× 50 0.6× 13 0.2× 120 1.9× 13 617

Countries citing papers authored by A. Prasanth Saraswati

Since Specialization
Citations

This map shows the geographic impact of A. Prasanth Saraswati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Prasanth Saraswati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Prasanth Saraswati more than expected).

Fields of papers citing papers by A. Prasanth Saraswati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Prasanth Saraswati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Prasanth Saraswati. The network helps show where A. Prasanth Saraswati may publish in the future.

Co-authorship network of co-authors of A. Prasanth Saraswati

This figure shows the co-authorship network connecting the top 25 collaborators of A. Prasanth Saraswati. A scholar is included among the top collaborators of A. Prasanth Saraswati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Prasanth Saraswati. A. Prasanth Saraswati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Saraswati, A. Prasanth, et al.. (2022). Recent Advances in the Discovery of Therapeutics to Curtail Islet Amyloid Polypeptide Aggregation for Type 2 Diabetes Treatment. Advanced Biology. 6(10). e2101301–e2101301. 7 indexed citations
2.
Fortin, Jessica S., A. Prasanth Saraswati, Mengyu Liu, et al.. (2022). Anti-fibrillization effects of sulfonamide derivatives on α-synuclein and hyperphosphorylated tau isoform 1N4R. Journal of Molecular Structure. 1267. 133574–133574. 9 indexed citations
3.
Relitti, Nicola, A. Prasanth Saraswati, Gabriele Carullo, et al.. (2022). Design and Synthesis of Oligopeptidic Parvulin Inhibitors. ChemMedChem. 17(11). e202200050–e202200050. 2 indexed citations
4.
Relitti, Nicola, A. Prasanth Saraswati, Giulia Chemi, et al.. (2020). Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation. European Journal of Medicinal Chemistry. 212. 112998–112998. 30 indexed citations
5.
Relitti, Nicola, A. Prasanth Saraswati, Stefano Federico, et al.. (2020). Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials. Current Topics in Medicinal Chemistry. 20(6). 433–457. 42 indexed citations
6.
Guidi, Alessandra, A. Prasanth Saraswati, Nicola Relitti, et al.. (2020). (+)-(R)- and (−)-(S)-Perhexiline maleate: Enantioselective synthesis and functional studies on Schistosoma mansoni larval and adult stages. Bioorganic Chemistry. 102. 104067–104067. 1 indexed citations
7.
Brindisi, Margherita, A. Prasanth Saraswati, Simone Brogi, et al.. (2019). Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases. Journal of Medicinal Chemistry. 63(1). 23–39. 86 indexed citations
8.
Saraswati, A. Prasanth, Nicola Relitti, Margherita Brindisi, et al.. (2019). Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors. Drug Discovery Today. 24(7). 1370–1388. 27 indexed citations
9.
Saccoccia, Fulvio, Margherita Brindisi, Nicola Relitti, et al.. (2019). Screening and Phenotypical Characterization of Schistosoma mansoni Histone Deacetylase 8 (SmHDAC8) Inhibitors as Multistage Antischistosomal Agents. ACS Infectious Diseases. 6(1). 100–113. 21 indexed citations
10.
Saraswati, A. Prasanth, S.M. Ali Hussaini, Namballa Hari Krishna, Bathini Nagendra Babu, & Ähmed Kamal. (2017). Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions. European Journal of Medicinal Chemistry. 144. 843–858. 103 indexed citations
11.
Nerella, Sridhar Goud, et al.. (2017). Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance. Current Medicinal Chemistry. 24(38). 4303–4314. 98 indexed citations
12.
Seddigi, Zaki S., M. Shaheer Malik, A. Prasanth Saraswati, et al.. (2017). Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents. MedChemComm. 8(8). 1592–1603. 62 indexed citations
13.
Krishna, Namballa Hari, A. Prasanth Saraswati, Manda Sathish, Nagula Shankaraiah, & Ahmed Kamal. (2016). Silver catalyzed domino aza-annulation/Diels–Alder cyclization of 2-ene-yne anilines: a facile one-pot access to carbazole, dihydrocarbazole and tetrahydrocarbazole frameworks. Chemical Communications. 52(24). 4581–4584. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026